New Additions to Drugs.com for 2011
The following 47 drugs were added to the Drugs.com database in 2011.
Edarbyclor
Dec 20, 2011 - Edarbyclor (azilsartan medoxomil and chlorthalidone) is a fixed-dose combination of an angiotensin II receptor blocker (ARB) and a diuretic, indicated for the treatment of hypertension.
Anturol
Dec 13, 2011 - Anturol (oxybutynin) is an anticholinergic transdermal gel formulation indicated for the management of overactive bladder.
Forfivo XL
Nov 30, 2011 - Forfivo XL (bupropion) is a high-strength formulation of the aminoketone antidepressant bupropion (contained in Wellbutrin) indicated for the treatment of major depressive disorder.
Intermezzo
Nov 24, 2011 - Intermezzo is a low dose, fast acting, sublingual formulation of the hypnotic agent zolpidem, indicated for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
Eylea
Nov 20, 2011 - Eylea and Eylea HD (aflibercept) are injectable eye preparations that may be given to treat certain retinal disorders such as neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity (Eylea only).
Erwinaze
Nov 20, 2011 - Erwinase (asparaginase Erwinia chrysanthemi) is an antineoplastic agent used to treat patients with acute lymphoblastic leukemia (ALL) who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegapargase chemotherapy drugs.
Jakafi
Nov 16, 2011 - Jakafi (ruxolitinib) is a Janus kinase (JAK) inhibitor indicated for the treatment of myelofibrosis, polycythemia vera, and graft versus host disease.
Exparel
Oct 31, 2011 - Exparel (bupivacaine) is an anesthetic (numbing medicine) that is used after surgery to provide local analgesia (pain relief in a small area) via infiltration for adults and children aged 6 and older and regional analgesia (pain relief in a larger area) in adults via an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block.
Ferriprox
Oct 26, 2011 - Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes and sickle cell disease.
Onfi
Oct 25, 2011 - Onfi (clobazam) is a benzodiazepine antiepileptic drug for the treatment of patients with Lennox-Gastaut syndrome (LGS).
Juvisync
Oct 7, 2011 - Juvisync (simvastatin and sitagliptin) is an HMG-CoA reductase inhibitor (statin) and dipeptidyl peptidase-4 (DPP-4) inhibitor fixed dose combination for the treatment of high cholesterol and type 2 diabetes.
Xalkori
Aug 26, 2011 -
Firazyr
Aug 26, 2011 - Firazyr (icatibant) is a selective B2 bradykinin receptor antagonist indicated for the treatment of acute attacks of hereditary angioedema.
Adcetris
Aug 26, 2011 -
Zelboraf
Aug 17, 2011 - Zelboraf (vemurafenib) is a kinase inhibitor indicated for the treatment of patients
with metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test, and for the treatment of patients with Erdheim-Chester Disease with BRAF V600 mutation.
Complera
Aug 11, 2011 - Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is a combination of three antiretroviral medications indicated for the once daily treatment of HIV-1 infection in treatment-naïve adults.
Anascorp
Aug 10, 2011 - Anascorp (Centruroides (Scorpion) Immune F(ab’)2 (Equine)) is an antivenom indicated for treatment of clinical signs of scorpion
envenomation.
Brilinta
Jul 21, 2011 - Brilinta (ticagrelor) is a P2Y12 platelet inhibitor indicated to reduce the risk of cardiovascular events in patients with a history of heart attack, acute coronary syndrome, coronary artery disease, or stroke.
Lazanda
Jul 6, 2011 - Lazanda (fentanyl) is an opioid analgesic nasal spray for the management of breakthrough pain in cancer patients.
Arcapta
Jul 2, 2011 - Arcapta (indacaterol inhalation powder) is a long-acting beta2-agonist (LABA) for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
Xarelto
Jul 2, 2011 - Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in patients with atrial fibrillation, for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), to reduce the risk of DVT and/or PE in certain at-risk patients, for the prevention of DVT in patients undergoing knee or hip replacement surgery, for the prevention of venous thromboembolism (VTE) in acutely ill medical patients, and in combination with aspirin to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
Rezira
Jun 29, 2011 - Rezira (hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive and
nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold.
Zutripro
Jun 29, 2011 - Zutripro (chlorpheniramine, hydrocodone and pseudoephedrine) Oral Solution is a combination product containing an antitussive, an antihistamine, and a nasal decongestant indicated for the relief of cough and nasal congestion associated with the common cold and upper respiratory allergies.
Rectiv
Jun 28, 2011 - Rectiv (nitroglycerin) is a topical ointment for the treatment of moderate to severe pain associated with chronic anal fissures.
Oxecta
Jun 21, 2011 - Oxecta (oxycodone hydrochloride) is an abuse-deterrent opioid analgesic formulation for the relief of moderate to severe pain.
Nulojix
Jun 16, 2011 - Nulojix (belatacept) is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant.
Potiga
Jun 13, 2011 - Potiga (ezogabine) is a potassium channel opener indicated for the adjunctive treatment of adults with partial-onset seizures.
Dificid
May 27, 2011 - Dificid (fidaxomicin) is a macrolide antibacterial drug indicated for the treatment of Clostridium difficile-associated diarrhea.
Victrelis
May 14, 2011 - Victrelis (boceprevir) is a hepatitis C virus (HCV) NS3/4A protease inhibitor
indicated for the treatment of chronic hepatitis C.
Tradjenta
May 3, 2011 - Tradjenta (linagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Zytiga
May 2, 2011 - Zytiga (abiraterone acetate) is a CYP17 inhibitor indicated for use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.
Duexis
Apr 28, 2011 - Duexis (ibuprofen and famotidine) is an NSAID and histamine H2-receptor antagonist combination indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper GI ulcers.
Sylatron
Apr 14, 2011 - Sylatron (peginterferon alfa-2b) is an alpha interferon indicated for the adjuvant treatment of melanoma.
Caprelsa
Apr 11, 2011 - Caprelsa (vandetanib) is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable (non-operable) locally advanced or metastatic disease.
Horizant
Apr 7, 2011 - Horizant (gabapentin enacarbil) is a gabapentin prodrug indicated for the once-daily treatment of moderate-to-severe primary Restless Legs Syndrome.
Yervoy
Mar 28, 2011 - Yervoy (ipilimumab) is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody indicated for the treatment of melanoma, renal cell carcinoma, microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, and malignant pleural mesothelioma.
Gadavist
Mar 15, 2011 - Gadavist (gadobutrol) is a gadolinium-based contrast agent indicated for intravenous use in diagnostic MRI in adults and children to detect and visualize areas with disrupted blood brain barrier and/or abnormal
vascularity of the central nervous system.
Benlysta
Mar 10, 2011 -
Daliresp
Mar 1, 2011 - Daliresp (roflumilast) is an orally administered phosphodiesterase 4 (PDE4) enzyme inhibitor indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with
chronic bronchitis and a history of exacerbations.
Corifact
Feb 21, 2011 - Corifact (factor XIII concentrate (human)) is a is a fibrin-stabilizing factor concentrate indicated to prevent bleeding in people with congenital Factor XIII deficiency.
Gralise
Feb 9, 2011 - Gralise (gabapentin) is an extended release, tablet formulation of the approved antiepileptic agent gabapentin, indicated for the once-daily treatment of post-herpetic neuralgia (PHN).
Makena
Feb 7, 2011 - Makena (hydroxyprogesterone caproate) is a long acting form of natural progesterone for the prevention of preterm birth in pregnant women with a history of at least one spontaneous preterm birth.
DaTscan
Jan 31, 2011 - DaTscan (ioflupane I 123 injection) is a radiopharmaceutical indicated for
striatal dopamine transporter visualization using single photon emission
computed tomography (SPECT) brain imaging to assist in the evaluation of
adult patients with suspected Parkinsonian syndromes (PS).
Natroba
Jan 28, 2011 - Natroba (spinosad) is a pediculicide indicated for the topical treatment of head lice infestations.
Viibryd
Jan 25, 2011 - Viibryd (vilazodone) is a dual-acting potent and selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist indicated for the treatment of major depressive disorder (MDD).
Abstral
Jan 12, 2011 - Abstral (fentanyl) is a sublingual opioid analgesic indicated for the management of breakthrough pain in cancer patients.
Fortesta
Jan 3, 2011 - Fortesta (testosterone) Gel is a topical androgen indicated for replacement therapy in male hypogonadism.